BJY-808

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBJY-808
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor receptor inhibitors
TargetsTumor necrosis factor receptor
Therapy Area/IndicationsEnteritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesEight Plus One Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEight Plus One Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsEnteritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A